Ribozyme based treatment of female reproductive diseases

Details for Australian Patent Application No. 2002344237 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 09/870,161 29.05.01 US; 10/138,674 03.05.02 US; 60/334,461 30.11.01 US

8 May 2003 Application Open to Public Inspection

Published as AU-B-2002344237

2 February 2006 Amendment Made

The nature of the amendment is: Delete the co-inventors Escobedo, Jaime, Stinchomb, Dan and Gordon, Gilad.

2 February 2006 Change of Name(s) of Applicant(s), Section 104

Ribozyme Pharmaceuticals, Inc. The name of the applicant has been changed to Sirna Therapeutics, Inc.

23 October 2008 Application Accepted

Published as AU-B-2002344237

6 November 2008 Corrigenda

Applications Accepted - Name Index Under the name Sirna Therapeutics, Inc., Application No. 2002344237, under INID(54), correct the invention title to Nucleic Acid Based Modulation of Female Reproductive Diseases and Conditions Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2003284049 Graphic Packaging International, Inc. 2004249054 Sato Sports Plaza Co., Ltd.; Japan

19 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.